NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. , ANNOUNCES LACRIFILL® CANALICULAR GEL INCLUSION IN NEW DRY EYE WORKSHOP III MANAGEMENT AND THERAPY REPORT FROM THE TEAR FILM AND OCULAR SURFACE SOCIETY IN AMERICAN JOURN

Nordic Pharma Pennsylvania

View original content:https://www.prnewswire.co.uk/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-lacrifill-canalicular-gel-inclusion-in-new-dry-eye-workshop-dews-iii-management-and-therapy-report-from-the-tear-film-and-ocular-surface-society-tf-302524112.html